The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

The EU is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the EU pharmaceutical industry.

It will address:

  • the life cycle of medicines from R&D to authorisation and patient access
  • how to put scientific and technological advances into practice
  • how to fill market gaps (e.g. new antimicrobials)
  • lessons learnt from COVID-19 on how to better prepare for future pandemics.

To read the pharmaceutical strategy roadmap, click here or visit the website,

 

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752

info@cddf.org
Tel: +32 2 880 62 70